Scip & Savor for a Cure Fundraiser Benefits the International Myeloma Foundation (IMF) and Family Reach Read more about Scip & Savor for a Cure Fundraiser Benefits the International Myeloma Foundation (IMF) and Family Reach Add new comment
FDA Approves Tecvayli (teclistamab-cqyv) for Relapsed or Refractory Multiple Myeloma Read more about FDA Approves Tecvayli (teclistamab-cqyv) for Relapsed or Refractory Multiple Myeloma Add new comment
4th Annual Schleicher's Hikers 5K Walk/Run Fundraiser Benefits Brian D. Novis Grants Read more about 4th Annual Schleicher's Hikers 5K Walk/Run Fundraiser Benefits Brian D. Novis Grants Add new comment
The Annual Miracles for Myeloma 5K Hybrid Run/Walk Celebrates 10th Anniversary Read more about The Annual Miracles for Myeloma 5K Hybrid Run/Walk Celebrates 10th AnniversaryAdd new comment
Exciting Developments in Myeloma Therapies and Treatments Read more about Exciting Developments in Myeloma Therapies and TreatmentsAdd new comment
International Myeloma Foundation (IMF) Launches M-Power New York to Improve Multiple Myeloma Outcomes in the Black Community Read more about International Myeloma Foundation (IMF) Launches M-Power New York to Improve Multiple Myeloma Outcomes in the Black CommunityAdd new comment
CDC Signs Off on Updated COVID-19 mRNA Boosters: Doses May Be Available as Early as September 2 Read more about CDC Signs Off on Updated COVID-19 mRNA Boosters: Doses May Be Available as Early as September 2 Add new comment
The International Myeloma Foundation (IMF) Highlights #kNOwMyeloma Campaign for Blood Cancer Awareness Month 2022 Read more about The International Myeloma Foundation (IMF) Highlights #kNOwMyeloma Campaign for Blood Cancer Awareness Month 2022Add new comment
How to Talk with Others About Your Multiple Myeloma Diagnosis Read more about How to Talk with Others About Your Multiple Myeloma DiagnosisAdd new comment
CDC Streamlines COVID-19 Guidance for the Public’s Better Protection and Easier Understanding of Risks Read more about CDC Streamlines COVID-19 Guidance for the Public’s Better Protection and Easier Understanding of Risks Add new comment
